(Q46867821)

26 December 2017

title

Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning (English)

1 reference

26 December 2017

1 reference

Mike R Schoenberg

2

0 references

author name string

Mary Ann Werz

1

1 reference

26 December 2017

Kimford J Meador

3

1 reference

26 December 2017

David W Loring

4

1 reference

26 December 2017

Patty G Ray

5

1 reference

26 December 2017

Rina Kaul-Gupta

6

1 reference

26 December 2017

Paula Ogrocki

7

1 reference

26 December 2017

publication date

27 December 2005

1 reference

26 December 2017

published in

Epilepsy Behavior

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

181-191

1 reference

26 December 2017

Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Patient-validated content of epilepsy-specific quality-of-life measurement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Quality of life of people with epilepsy: a European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

The impact of epilepsy from the patient's perspective II: views about therapy and health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Optimizing health outcomes in active epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Depression in epilepsy: a frequently neglected multifaceted disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Psychiatric uses of antiepileptic treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Outcomes research: measuring the end results of health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Topiramate: as monotherapy in newly diagnosed epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Comparative cognitive effects of carbamazepine and phenytoin in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Differential cognitive and behavioral effects of carbamazepine and lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Central Anticholinergic Hypersensitivity in Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Evaluating storage, retention, and retrieval in disordered memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

A meta-analytic review of verbal fluency performance following focal cortical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

The Neurotoxicity Scale: the validity of a patient-based scale, assessing neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Development of the quality of life in epilepsy inventory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Validation of the side effect and life satisfaction (SEALS) inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

The Current Understanding of Lamotrigine as a Mood Stabilizer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Cognitive and behavioral effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Improved mood states with lamotrigine in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Effects of topiramate on cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

The effects of adjunctive topiramate on cognitive function in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Differential cognitive and behavioral effects of topiramate and valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

The relationship of neuropsychological functioning to quality of life in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.09.003

10.1016/J.YEBEH.2005.09.003

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

release_m3iy4g7njrerzh2flxlhti4gga

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m3iy4g7njrerzh2flxlhti4gga

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

26 December 2017